Updated January 23, 2008
GlaxoSmithKline to Close Tennessee Plant by 2009
Post a comment
Print this storyE-mail story
Share
BRISTOL, Tenn. —
GlaxoSmithKline will begin laying off its workforce at a drug-manufacturing plant in Bristol in April 2009 and shutter the plant by Oct. 31, the company said Wednesday.
The 400,000-square-foot plant makes the penicillin drug Augmentin.
GSK first announced plans in 2006 to close the plant due to declining sales of Augmentin. The plant currently employs 236 people. At its peak, the plant had more than 400 workers, according to the Herald-Courier newspaper in Bristol.
Featured
Hot Off The Wire
- Hot Off the Wire – Net naming agency reconsiders ‘xxx’ domain; Huge botnet taken down; Google to digitize historic books in Rome, Florence
- Hot Off the Wire – MySpace plans makeover after exec shakeup; Early PC designer wins Turning technology award; Cisco competitor share’s jump
- Hot Off the Wire – GSK pays $40M to close deal with Maryland firm; Sprint plans to cut debt; Google backs easing of software exports
Venture & Innovation
- Venture Briefs – A top VC uses blog to generate wider dealfow; CA pays $350M for cloud computing firm; Battery closes on $750M fund
- Venture briefs – 10th birthday for ‘dot-com bubble’ peak; ‘Startup Bus’ teams entrepreneurs for ideas; Carried interest debate is back; Weebly adds theme site creation tool
- Duke team wins regional Association for Corporate Growth event
